24/7 Market News Snapshot 08 January, 2025 – 60 Degrees Pharmaceuticals, Inc. Common Stock (NASDAQ:SXTP)

January 8, 2025

DENVER, Colo., 08 January, 2025 (247marketnews.com) – (NASDAQ:SXTP) are discussed in this article.
60 Degrees Pharmaceuticals, Inc. (SXTP) is experiencing significant momentum in the market, with its stock price surging 55.29% to $2.174 during pre-market trading, an impressive rebound from the previous close of $1.400. The trading session has reported a robust volume of 7.19 million shares, highlighting a notable increase in investor interest and confidence. This escalation positions SXTP as a potential candidate for further gains, prompting traders to monitor the situation closely as market dynamics evolve.

Amid this market enthusiasm, 60 Degrees Pharmaceuticals has announced a pivotal milestone in its clinical research efforts with the enrollment of the first patient in its expanded access clinical study, NCT06478641. This study focuses on evaluating the efficacy of tafenoquine for persistent cases of babesiosis, particularly those that have proven resistant to conventional therapies. This initiative follows encouraging case reports with a remarkable 80% cure rate among patients who had previously failed multiple treatment regimens.

Babesiosis, a severe tick-borne illness, presents significant challenges, particularly for immunocompromised patients, who are at greater risk of severe complications without adequate treatment options. 60 Degrees Pharmaceuticals believes that tafenoquine has the potential to offer new hope to these patients. Dr. Geoff Dow, CEO of the company, expressed optimism regarding the study, emphasizing its role in addressing the urgent needs of patients and healthcare providers confronting this complex disease.

Tafenoquine is already FDA-approved for malaria prophylaxis under the brand ARAKODA®, and the current study seeks to explore its application in treating babesiosis, targeting an estimated 400,000 individuals in the market during the remaining period of U.S. patent protection. The company is committed to advancing innovative healthcare solutions and is actively inviting interested physicians and qualified patients to participate in this crucial research.

Related news for (SXTP)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.